Ascletis Pharma
A biotechnology company that develops and discovers anti-viral drugs and treatments for cancer and fatty liver disease. Ascletis is a joint venture between entrepreneurs in the U.S. and China.
1
Funding Rounds
$100.0m
Money raised
Overview
A biotechnology company that develops and discovers anti-viral drugs and treatments for cancer and fatty liver disease. Ascletis is a joint venture between entrepreneurs in the U.S. and China.
- Website:
- Headquarters: Hangzhou
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company Ascletis Pharma has raised a total of $100m in funding over 1 rounds.
Key Insights:
- Ascletis Pharma Series B round, January 2017: $100m
Ascletis Pharma Series B round, January 2017
$100m
Industries
Ascletis Pharma is active in the following industries:
- Technology
- Biotechnology
- Biology
- RNA-based and RNA-targeted therapeutics